Rezultati pretraživanja
  1. 18. tra 2018.

    The circadian clock and cancer - it's all in the timing

  2. Thought-provoking read from on why the industry’s reconfiguration of cancer R&D is essential.

  3. In cool science news. In case you missed this from - on their development of an "Augmented Reality Microscope for Cancer Detection"

  4. 18. tra 2018.

    Pediatric Oncology Branch’s ACI Dr. Christine Heske gets nice foot traffic for her poster on Ewing’s sarcoma at

  5. 18. tra 2018.

    This is new! Single-tube RNA library prep followed by "one click" fully automated bioinformatics. Learn more at Diagenode booth 1220,

  6. "We spent 20 years personalizing targeted therapies, and we are now moving toward personalized immunotherapies," says

  7. After 6 months of listening & learning from people across the cancer community, I highlighted some key areas of focus for at this week. If you missed it, be sure to check out my blog post:

  8. One of the most interesting sessions was the Forum on “Is Genome-Informed Cancer Medicine Generating Patient Benefit or Just Hype?,” featuring a debate between and @VinayPrasadMD. Audio and slides are now available on the meeting webcast:

  9. HaoRan Tang from our Molecular Oncology group presenting his fantastic work in collaboration with our Drug Discovery Unit on LOX regulation of EGFR & tumour progression/invasion at the last poster session of

  10. 18. tra 2018.

    Cheri Pasch from our lab presenting her patient-derived organotypic cancer steroid work at . Great work Cheri!!!

  11. 18. tra 2018.

    Presenting insights learned and data from the at now. So much enthusiasm for the approach, lessons learned and ability to conduct in such an exceedingly rare indication.

  12. "Unsolved Mysteries" were among the most interesting sessions at . In the session, "Failure to Translate: The IGF-1R and PI3K Inhibitors," Carlos Arteaga and Valentine Macaulay discussed the challenges presented by these targets. View the webcast:

  13. 17. tra 2018.

    The Kyn Team is presenting our IDO/TDO programs at today. Here is Karen McGovern, VP Drug Discovery, handling the crowd at one of our posters.

  14. highlights: reversing drug resistance in ER-positive breast cancer

  15. What caught our eye at ? Find out in our first-ever list of :

  16. dominated the headlines at . Our science writer highlights news on biomarkers, data sharing, and personalized medicine:

  17. Congrats to Winship oncologist who has received an Lymphoma Research Fellowship. Funding from the two-year grant will support her research project, "B cell repertoire, genetic abnormalities, and outcomes in B cell lymphoma."

  18. Why I love my patient/advocate friends? They bring everything to the table. Many thanks to , and Sheila for walking scientists through our poster. Data presented from patients? Priceless.

  19. Here’s Francesca Chemi from our CEP group with her WICR winning poster at this week. Congratulations!

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.